Devices

Nano-Sized Power Source for Implants & Medical Devices: an ATP-driven, Molecular Based Rotation Engine
The National Cancer Institute seeks CRADA partners to develop a working model of a molecular-base rotation engine which is constructed of two cylinders, one inner and one outer whose inner surfaces are coated (more...)
(Full Text)

Molecular-Based Computing Device
Background: NCI seeks partners to work with the Laboratory of Experimental and Computational Biology to develop a working prototype of this protein-based computer. This collaboration is open for a multi-party collaboration where one collaborator provides (more...)
(Full Text)

A Novel MRI RF Receiving Network Transformer for Parallel Imaging
The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) seeks a Cooperative Research and Development Agreement (CRADA) Collaborator to work with NINDS in the development, manufacture and commercialization of (more...)
(Full Text)

Nanoscale Detection Macromolecules
Background: The National Cancer Institute, Center for Cancer Research Nanobiology Program seeks a research partnership to develop devices that can be used to detect and/or selectively modify biomolecules. Possible uses of the nanoprobes include detection (more...)
(Full Text)

Intracellular RNA Sequencer
The National Cancer Institute, Center for Cancer Research Nanobiology Program seeks a research and development partner to develop a single molecule sequencing device. The MedusaJ Sequencer consists of a DNA or (more...)
(Full Text)

Bioinformatic Tools for Genomic DNA Sequence Dimorphisms (Indels)
Background: The National Cancer Institute, Center for Cancer Research, Mouse Cancer Genetics Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize identification and use (more...)
(Full Text)

Biotinylated Alkylating Acridine for Pull-downs of Viral Pre-integration Complexes (PIC) or Other Cytosol Localized DNAs

(Full Text)

Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-
Background: The National Institutes of Health, National Center for Complementary and Alternative Medicine, Diabetes Unit is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize phospho-specific (more...)
(Full Text)

Quantitative Determination of Marker Proteins in Complex Mixtures
Background: The Laboratory of Neurotoxicology of the National Institute of Mental Health and the Laboratory of Cell Biology of the National Cancer Institute are seeking statements of capability or interest from parties interested in forming (more...)
(Full Text)

3-D Imaging and Mass Spectrometry of Mammalian Cells
Background: The National Cancer Institute's Cell Biology Laboratory is seeking statements of capability or interest from parties interested in collaborative research and/or partnership agreements to further develop and commercialize tools for three-dimensional mapping of cells (more...)
(Full Text)

A New Technology for Identification of Hypoxia-Dependent Transcriptional Activation
Background: The Screening Technologies Branch of the National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to obtain pre-clinical data to be used to further develop, evaluate, or (more...)
(Full Text)

Imaging System for Correlative Electron/Confocal Fluorescence Microscopy
Background: The National Cancer Institute's Cell Biology Laboratory is seeking statements of interest or capability from parties interested in collaborative research agreements to further develop and commercialize a methodology and device for the microscopic examination (more...)
(Full Text)

Human and Improved Murine Monoclonal Antibodies Against CD22
Background: The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize human monoclonal antibodies expressed in types of lymphoma. CD22 is (more...)
(Full Text)

Carbon Nanotube Transistor -Based Microarray Binding Sensors
Background: The National Cancer Institute's Oncogenomics Section is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize electronic detection of nucleic acid and protein levels. Description of Technology: This (more...)
(Full Text)

Optical Cells with Biological Applications
Background: NICHD is seeking statements of capability or interest from parties interested in collaborative research and/or partnership agreements to develop, evaluate, or commercialize optical cells with tissue pathology diagnostic applications. Apart from pathology diagnostics, potential applications (more...)
(Full Text)

Magnetic Resonance Imaging Method For Estimating Cone Of Uncertainty
Background: The National Institute of Child Health and Human Development (NICHD), Section on Tissue Biophysics and Biomimetics, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, (more...)
(Full Text)